![Sample our Behavioral Sciences journals, sign in here to start your access, latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110801/TOC-Subject-Sample-2021-Behavioral-Sciences.jpg"})
ABSTRACT
Objectives: Smokers with posttraumatic stress disorder (PTSD) have increased difficulty achieving and maintaining abstinence. Contingency management approaches to smoking cessation interventions have demonstrated short-term efficacy but are limited by high rates of relapse. The goal of this pilot study was to evaluate the usability and feasibility of a smartphone-based smoking cessation application (Stay Quit Coach) designed to prevent relapse among individuals with PTSD. Methods: Smokers (N = 11) were randomized to (1) QUIT4EVER, an intervention combining mobile contingency management smoking cessation counseling and medications, and Stay Quit Coach or (2) a contact control condition that was identical to QUIT4EVER except Stay Quit Coach was not included. The primary outcome was prolonged smoking abstinence. Results: Among those queried during the follow-up periods, average Stay Quit Coach helpfulness ratings were high and ranged from 7.25 to 10 on a 10-point Likert scale (with higher scores corresponding to greater helpfulness). The Stay Quit Coach was rated by participants as being most effective at helping to quit smoking, helping to remain quit, and providing support and relevant information about quitting. Among the three quitters in the QUIT4EVER group, all reported abstinence at 3 and 6 months; however, abstinence was only bioverified for one quitter at 6 months. Among the four quitters in the contact control condition group, three reported abstinence at 3 and 6 months, but abstinence was not confirmed by bioverification. Conclusions: Smokers with PTSD express interest in and helpfulness of Stay Quit Coach for remaining abstinent after a quit attempt. Combined use of mobile contingency management and Stay Quit Coach is a feasible and acceptable adjunctive smoking cessation treatment for reducing smoking among smokers with PTSD. Adequately powered clinical trials are needed to demonstrate the long-term efficacy of this combined approach to smoking cessation. This study [Use of Technological Advances to Prevent Smoking Relapse among Smokers with PTSD (QUIT4EVER)] was registered on www.clinicaltrials.gov. clinicaltrials.gov identifier: NCT01990079.
Acknowledgments
Mr. Hicks was supported by the National Cancer Institute of the National Institutes of Health under award number R01CA196304-02S1. Preparation of this manuscript was also supported by the U.S. Department of Veterans Affairs (VA) Clinical Sciences Research and Development Senior Research Career Scientist Award, 1lK6CX001494 (Beckham); the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center; the VA Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment (Wilson); Veterans Health Administration (VHA) Office of Research and Development, Clinical Science Research and Development; the VHA Tobacco & Health: Policy and Programs; and the National Center for PTSD Palo Alto. Funding sources had no role in the design, execution, analysis, interpretation of the data, or the decision to submit results for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the VA or the U.S. government or any of the institutions with which the authors are affiliated.
Disclosures
The authors have no competing financial interests to report.
Funding
Funding for this study came from an internal funding mechanism, Duke University School of Medicine Bridge Funding Program, and the National Cancer Institute (R01CA196304-02S1), Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment, and U.S. Department of Veterans Affairs Clinical Sciences Research and Development Senior Research Career Scientist Award (1lK6CX001494).
